Anne Stirling

TL;DR: A strategy of intensive outpatient management of rheumatoid arthritis substantially improves disease activity, radiographic disease progression, physical function, and quality of life at no additional cost.

TL;DR: In early RA, a MSUS-driven T2T strategy led to more intensive treatment, but was not associated with significantly better clinical or imaging outcomes than a DAS28-driven strategy.

TL;DR: This study confirms that highly effective control of disease activity can be achieved using conventional DMARDs as part of an intensive disease management strategy and within this setting, step-up therapy is at least as effective as parallel triple therapy.

TL;DR: Combined low intensity laser and phototherapy, used under these conditions, does not appear useful for altering the course of rheumatoid arthritis.

TL;DR: Etanercept therapy was associated with a fall in SAA levels in seven of nine patients, five of whom achieved levels which might be expected to be associated with stable or regressing amyloid deposits, and represents a useful alternative to immunosuppressant therapy such as cyclophosphamide or chlorambucil.